PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för fludarabine phosphate. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

16 hits

Bibliografisk träff 2011-09-11

A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.

McCune JS, Woodahl EL, Furlong T, Storer B, Wang J, Heimfeld S, Deeg HJ, O'Donnell PV.

Cancer Chemother Pharmacol · clinical trial, phase ii; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1007/s00280-011-1736-3

Bibliografisk träff 2011-07-04

Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

Yeh RF, Pawlikowski MA, Blough DK, McDonald GB, O'Donnell PV, Rezvani A, Deeg HJ, McCune JS.

Biol Blood Marrow Transplant · clinical trial; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bbmt.2011.06.013

Bibliografisk träff 2011-07-02

Rituximab in chronic lymphocytic leukemia.

James DF, Kipps TJ.

Adv Ther · research support, non-u.s. gov't; research-article; review; journal article · DOI 10.1007/s12325-011-0032-2

Bibliografisk träff 2011-02-03

Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.

Shea T, Johnson J, Westervelt P, Farag S, McCarty J, Bashey A, Isola L, Baxter-Lowe LA, Kelly M, Owzar K, Linker C, Cancer and Leukemia Group B.

Biol Blood Marrow Transplant · clinical trial, phase ii; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bbmt.2011.01.016

Bibliografisk träff 2010-08-05

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.

Ungerechts G, Frenzke ME, Yaiw KC, Miest T, Johnston PB, Cattaneo R.

Gene Ther · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/gt.2010.103

Bibliografisk träff 2010-07-01

Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines.

Pierigè F, De Marco C, Orlotti N, Dominici S, Biagiotti S, Serafini S, Zaffaroni N, Magnani M, Rossi L.

Int J Oncol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.3892/ijo_00000661

Bibliografisk träff 2010-05-14

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.

Tai CK, Wang W, Lai YH, Logg CR, Parker WB, Li YF, Hong JS, Sorscher EJ, Chen TC, Kasahara N.

Cancer Gene Ther · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/cgt.2010.17

Bibliografisk träff 2010-03-09

Successful treatment of cutaneous intravascular large B-cell lymphoma with fludarabine phosphate.

Shan SJ, Chen J, Geng SL, Hong Y, Xu H, Guo Y, Wei H, Zhai M, Chen HD.

Eur J Dermatol · letter; case reports · DOI 10.1684/ejd.2010.0922

Bibliografisk träff 2010-01-01

Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate.

Yin W, Karyagina EV, Lundberg AS, Greenblatt DJ, Lister-James J.

Biopharm Drug Dispos · research support, non-u.s. gov't; journal article · DOI 10.1002/bdd.690

Bibliografisk träff 2009-08-01

[Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].

Maeda A, Iwai K, Ishibashi T.

Rinsho Ketsueki · journal article; english abstract; case reports

Bibliografisk träff 2009-06-01

Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.

Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane K, White S, Thomas S.

Health Technol Assess · research support, non-u.s. gov't; journal article · DOI 10.3310/hta13suppl1/06

Bibliografisk träff 2009-03-13

Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.

MacKenna DA, Montag A, Boyer SH, Linemeyer DL, Erion MD.

Cancer Chemother Pharmacol · journal article · DOI 10.1007/s00280-009-0953-5

Bibliografisk träff 2000-03-01

In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.

Kano Y, Akutsu M, Tsunoda S, Suzuki K, Ichikawa A, Furukawa Y, Bai L, Kon K.

Leukemia · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1038/sj.leu.2401684

Bibliografisk träff 1996-06-01

Fludarabine phosphate: A DNA synthesis inhibitor with potent immunosuppressive activity and minimal clinical toxicity.

Goodman ER, Fiedor PS, Fein S, Athan E, Hardy MA.

Am Surg · journal article

Bibliografisk träff 1995-08-01

Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas.

Fenchel K, Bergmann L, Wijermans P, Engert A, Pralle H, Mitrou PS, Diehl V, Hoelzer D.

Leuk Lymphoma · clinical trial; journal article · DOI 10.3109/10428199509059649

Bibliografisk träff 1994-01-01

Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.

Keating MJ, McLaughlin P, Plunkett W, Robertson LE, O'Brien S, Gandhi V, Gregoire V, Yang L, Cabanillas F.

Ann Oncol · review; journal article · DOI 10.1093/annonc/5.suppl_2.s79